The drugs and devices have been on the market for years. But FDA-ordered studies still aren’t done. - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

The drugs and devices have been on the market for years. But FDA-ordered studies still aren’t done.

“Doctors rely on this evidence, patients rely on this evidence, and if that evidence is not there, it’s going to lead to a lot of uncertainty."

  • By

  • David Hilzenrath

  • September 22, 2026

  • 14 min

Share

Original Source(s)

The drugs and devices have been on the market for years. But FDA-ordered studies still aren’t done.

  • by David Hilzenrath

  • September 22, 2026

Related Content

STAT6 may aid diagnosis of giant pulmonary SFT

Immunohistochemical testing confirmed a rare tumor despite low-grade histology, extensive local involvement, and suspected liver metastasis.

FDA approves first therapy for symptomatic dermographism

The oral BTK inhibitor produced a complete hive response in 29.3% of treated patients at week 12.

Ureteral obstruction linked to degenerative sacroiliitis

CT identified an unusual cause of hydronephrosis despite stable renal function and no urinary symptoms.